MeMed Diagnostics Ltd - Product Pipeline Analysis, 2023 Update


MeMed Diagnostics Ltd (MeMed) is a developer of diagnostic solutions for inflammatory and infectious diseases. The company’s products include ImmunoXpert which is an in-vitro diagnostic test used for diagnosing the difference between bacterial and viral infections. It provides ImmunoPoC, a hand-held instrument used for the diagnosis of bacterial versus viral infections. MeMed offers services in varied fields including molecular immunology, clinical infectious diseases, informatics and in vitro diagnostics. The company uses its technology to discover, develop and validate novel diagnostic solutions. It partners with various academic, clinical and commercial partners. The company operates through its manufacturing and research and development facilities in Israel. MeMed is headquartered in Tirat Carmel, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company MeMed Diagnostics Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

MeMed Diagnostics Ltd Company Overview
MeMed Diagnostics Ltd Company Snapshot
MeMed Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
MeMed Diagnostics Ltd – Pipeline Analysis Overview
MeMed Diagnostics Ltd - Key Facts
MeMed Diagnostics Ltd - Major Products and Services
MeMed Diagnostics Ltd Pipeline Products by Development Stage
MeMed Diagnostics Ltd Pipeline Products Overview
Diagnostic Test - COVID-19
Diagnostic Test - COVID-19 Product Overview
ImmunoPoC Product Overview
MeMed Alert
MeMed Alert Product Overview
MeMed COVID-19 Severity Test
MeMed COVID-19 Severity Test Product Overview
MeMed ImmnuoRNA
MeMed ImmnuoRNA Product Overview
MeMed Neo
MeMed Neo Product Overview
MeMed Sepsis
MeMed Sepsis Product Overview
MeMed Ultra Flu
MeMed Ultra Flu Product Overview
MeMed Diagnostics Ltd - Key Competitors
MeMed Diagnostics Ltd - Key Employees
MeMed Diagnostics Ltd - Locations And Subsidiaries
Head Office
Recent Developments
MeMed Diagnostics Ltd, Recent Developments
Nov 06, 2023: MeMed Bolsters Leadership Team With Appointment of Ori Hadomi as Chairman and Peter Scheu as President of MeMed US
Oct 24, 2023: MeMed awarded US BARDA Contract to Demonstrate Clinical Utility of the FDA-Cleared MeMed BV Test for Distinguishing Bacterial From Viral infections
Jul 20, 2023: FDA grants 510(k) clearance for MeMed BV test on whole blood samples
Jul 19, 2023: MeMed: FDA Clears Pioneering MeMed BV Test Direct From Whole Blood Allowing Faster Time To Result And Broader Patient Access When Distinguishing Bacterial From Viral Infections
Jul 12, 2023: MeMed Diagnostics Receives Additional 510(k) Clearance for MeMed BV
May 25, 2023: Nutex Health announces agreement with MeMed to adopt pioneering MeMed BV test across its network of 19 sites
Apr 18, 2023: Clinical data validate pioneering MeMed BV technology improves diagnosis of pediatric patients with fever in the Emergency Department
Apr 12, 2023: MeMed Diagnostics receives additional 510(k) clearance for MeMed BV
Jan 31, 2023: Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections
Dec 22, 2022: Tulsa ER & Hospital adopts trailblazing MeMed BV Test
About GlobalData
Contact Us
List of Tables
Table 1: MeMed Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
Table 2: MeMed Diagnostics Ltd Pipeline Products by Equipment Type
Table 3: MeMed Diagnostics Ltd Pipeline Products by Indication
Table 4: MeMed Diagnostics Ltd, Key Facts
Table 5: MeMed Diagnostics Ltd, Major Products and Services
Table 6: MeMed Diagnostics Ltd Number of Pipeline Products by Development Stage
Table 7: MeMed Diagnostics Ltd Pipeline Products Summary by Development Stage
Table 8: Diagnostic Test - COVID-19 - Product Status
Table 9: Diagnostic Test - COVID-19 - Product Description
Table 10: ImmunoPoC - Product Status
Table 11: ImmunoPoC - Product Description
Table 12: MeMed Alert - Product Status
Table 13: MeMed Alert - Product Description
Table 14: MeMed COVID-19 Severity Test - Product Status
Table 15: MeMed COVID-19 Severity Test - Product Description
Table 16: MeMed ImmnuoRNA - Product Status
Table 17: MeMed ImmnuoRNA - Product Description
Table 18: MeMed Neo - Product Status
Table 19: MeMed Neo - Product Description
Table 20: MeMed Sepsis - Product Status
Table 21: MeMed Sepsis - Product Description
Table 22: MeMed Ultra Flu - Product Status
Table 23: MeMed Ultra Flu - Product Description
Table 24: MeMed Diagnostics Ltd, Key Employees
Table 25: Glossary
List of Figures
Figure 1: MeMed Diagnostics Ltd Pipeline Products by Equipment Type
Figure 2: MeMed Diagnostics Ltd Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings